Key Insights

Highlights

Success Rate

91% trial completion (above average)

Published Results

19 trials with published results (12%)

Research Maturity

80 completed trials (51% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.1%

8 terminated out of 158 trials

Success Rate

90.9%

+4.3% vs benchmark

Late-Stage Pipeline

15%

24 trials in Phase 3/4

Results Transparency

24%

19 of 80 completed with results

Key Signals

19 with results91% success

Data Visualizations

Phase Distribution

131Total
Not Applicable (93)
P 1 (2)
P 2 (12)
P 3 (7)
P 4 (17)

Trial Status

Completed80
Recruiting25
Not Yet Recruiting18
Unknown18
Terminated8
Withdrawn4

Trial Success Rate

90.9%

Benchmark: 86.6%

Based on 80 completed trials

Clinical Trials (158)

Showing 20 of 20 trials
NCT07855068Phase 4Not Yet RecruitingPrimary

Effect of a Low-Dose Ketamine-Dexmedetomidine-Based Opioid-Sparing Anesthesia Protocol on Postoperative Quality of Recovery After Percutaneous Nephrolithotomy

NCT07854743CompletedPrimary

Outcomes and Inter-Stage Interval in Staged Bilateral PCNL

NCT07835113Not ApplicableNot Yet RecruitingPrimary

Tissue Sensor for Semirigid Thulium Fiber Laser Ureterolithotripsy

NCT07668817Not ApplicableRecruitingPrimary

Tract Closure in PCNL

NCT07825142Phase 4Not Yet Recruiting

A Randomized, Double-Blind, Placebo-Controlled Trial of Anrikefon for Postoperative Analgesia After Percutaneous Nephrolithotomy

NCT07798336Not ApplicableNot Yet Recruiting

6.3Fr Versus 7.5Fr Mini-Flexible Ureteroscopy for Renal Stones (MINI-FURS)

NCT07718802Not ApplicableRecruitingPrimary

Observational Approach Versus Surgical Intervention for Stones

NCT06330246Not ApplicableRecruiting

O. Formigenes Colonization in Calcium Oxalate Kidney Stone Disease

NCT06331546Not ApplicableRecruiting

Gut Oxalate Absorption in Calcium Oxalate Stone Disease

NCT04669886RecruitingPrimary

Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.

NCT06989320Not ApplicableRecruiting

Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease

NCT07183930Not ApplicableCompletedPrimary

Tubeless vs Tube PCNL in Pediatric Nephrolithiasis

NCT07772830CompletedPrimary

Preoperative Anxiety in Patients Undergoing RIRS and PCNL

NCT07072598Not ApplicableWithdrawn

Comparing Efficiency and Stone-Free Rates Mini PCNL vs Flex URS

NCT03346369Phase 3Completed

Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis

NCT07749807Not ApplicableNot Yet Recruiting

Nebulized Glubran 2-Assisted Tubeless PCNL Versus Conventional PCNL

NCT07712861Not ApplicableNot Yet Recruiting

DISON I - Directly Integrated Suction and Optics System for the Treatment of Nephrolithiasis

NCT06653738Phase 3Recruiting

Trial to Assess the Efficacy of EMPAgliflozin and Personalized Dietary Counseling for Kidney STONE Prevention

NCT07457983Not ApplicableCompleted

Erector Spinae Plane Block for Percutaneous Nephrolithotomy

NCT07715643Not ApplicableCompletedPrimary

Vitamin E Supplementation Effect in Management of Calcium Oxalate Crystals

Scroll to load more

Research Network

Activity Timeline